Np mrd loader

Record Information
Version2.0
Created at2020-12-09 01:30:27 UTC
Updated at2021-07-15 16:47:54 UTC
NP-MRD IDNP0003977
Secondary Accession NumbersNone
Natural Product Identification
Common NameDolastatin 16
Provided ByNPAtlasNPAtlas Logo
Description Dolastatin 16 is found in Lyngbya majuscula. Dolastatin 16 was first documented in 2002 (PMID: 11809058). Based on a literature review very few articles have been published on (6S,12R,15R,18S,24S,31S)-5,30-dihydroxy-13,24,27-trimethyl-3-(1-phenylpropan-2-yl)-12,15,28-tris(propan-2-yl)-16,25-dioxa-1,4,10,13,22,29-hexaazatetracyclo[29.3.0.0⁶,¹⁰.0¹⁸,²²]Tetratriaconta-4,29-diene-2,11,14,17,23,26-hexone (PMID: 29019684) (PMID: 29863061) (PMID: 28074955) (PMID: 25689568).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC47H70N6O10
Average Mass879.1090 Da
Monoisotopic Mass878.51534 Da
IUPAC Name(3R,6S,12R,15R,18S,24S,27R,28S,31S)-13,24,27-trimethyl-3-[(2R)-1-phenylpropan-2-yl]-12,15,28-tris(propan-2-yl)-16,25-dioxa-1,4,10,13,22,29-hexaazatetracyclo[29.3.0.0^{6,10}.0^{18,22}]tetratriacontan-2,5,11,14,17,23,26,30-octone
Traditional Name(3R,6S,12R,15R,18S,24S,27R,28S,31S)-12,15,28-triisopropyl-13,24,27-trimethyl-3-[(2R)-1-phenylpropan-2-yl]-16,25-dioxa-1,4,10,13,22,29-hexaazatetracyclo[29.3.0.0^{6,10}.0^{18,22}]tetratriacontan-2,5,11,14,17,23,26,30-octone
CAS Registry NumberNot Available
SMILES
CC(C)C1NC(=O)[C@@H]2CCCN2C(=O)C(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)N(C)C(=O)[C@H](OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)OC(=O)C1C)C(C)C)C(C)CC1=CC=CC=C1
InChI Identifier
InChI=1S/C47H70N6O10/c1-26(2)36-30(8)46(60)62-31(9)42(56)53-24-16-21-35(53)47(61)63-39(28(5)6)45(59)50(10)38(27(3)4)44(58)52-23-15-20-34(52)41(55)49-37(29(7)25-32-17-12-11-13-18-32)43(57)51-22-14-19-33(51)40(54)48-36/h11-13,17-18,26-31,33-39H,14-16,19-25H2,1-10H3,(H,48,54)(H,49,55)/t29?,30?,31-,33-,34-,35-,36?,37?,38+,39+/m0/s1
InChI KeyJXOFEBNJOOEXJY-NLKHYCKVSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Lyngbya majusculaNPAtlas
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP3.63ALOGPS
logP3.96ChemAxon
logS-4.6ALOGPS
pKa (Strongest Acidic)12.4ChemAxon
pKa (Strongest Basic)-2.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area192.04 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity232.32 m³·mol⁻¹ChemAxon
Polarizability94.54 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
NPAtlas IDNPA002992
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID154450
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound177386
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Nogle LM, Gerwick WH: Isolation of four new cyclic depsipeptides, antanapeptins A-D, and dolastatin 16 from a Madagascan collection of Lyngbya majuscula. J Nat Prod. 2002 Jan;65(1):21-4. doi: 10.1021/np010348n. [PubMed:11809058 ]
  2. Petitbois JG, Casalme LO, Lopez JAV, Alarif WM, Abdel-Lateff A, Al-Lihaibi SS, Yoshimura E, Nogata Y, Umezawa T, Matsuda F, Okino T: Serinolamides and Lyngbyabellins from an Okeania sp. Cyanobacterium Collected from the Red Sea. J Nat Prod. 2017 Oct 27;80(10):2708-2715. doi: 10.1021/acs.jnatprod.7b00449. Epub 2017 Oct 11. [PubMed:29019684 ]
  3. Liang TT, Zhao Q, He S, Mu FZ, Deng W, Han BN: Modeling Analysis of Potential Target of Dolastatin 16 by Computational Virtual Screening. Chem Pharm Bull (Tokyo). 2018;66(6):602-607. doi: 10.1248/cpb.c17-00966. [PubMed:29863061 ]
  4. Casalme LO, Yamauchi A, Sato A, Petitbois JG, Nogata Y, Yoshimura E, Okino T, Umezawa T, Matsuda F: Total synthesis and biological activity of dolastatin 16. Org Biomol Chem. 2017 Feb 1;15(5):1140-1150. doi: 10.1039/c6ob02657e. [PubMed:28074955 ]
  5. Pettit GR, Smith TH, Arce PM, Flahive EJ, Anderson CR, Chapuis JC, Xu JP, Groy TL, Belcher PE, Macdonald CB: Antineoplastic agents. 599. Total synthesis of dolastatin 16. J Nat Prod. 2015 Mar 27;78(3):476-85. doi: 10.1021/np500925y. Epub 2015 Feb 17. [PubMed:25689568 ]